Evidence map›Paper›PMID 24510731›Full record

ReviewJournal of gastrointestinal cancer2014

Rare benign tumors of the liver: still rare?

Gaetano Bertino, Annalisa Ardiri, Shirin Demma, Stefano GiuseppeCalvagno, Adriana Toro, Elisa Basile, Davide Campagna, Giorgia Ferraro, Evelise Frazzetto, Maria Proiti and 7 more

Abstract readReview
In one paragraph

Review in Journal of gastrointestinal cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Liver tumors in children with chronic liver diseases.World journal of gastrointestinal oncology · 2021
    Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Gaetano BertinoHepatology Unit, Department of Medical and Pediatric Science, University of Catania, Policlinic-Via S. Sofia n. 78, 95123, Catania, Italy, gaetanobertinounict@libero.it.
Annalisa Ardiri
Shirin Demma
Stefano GiuseppeCalvagno
Adriana Toro
Elisa Basile
Davide Campagna
Giorgia Ferraro
Evelise Frazzetto
Maria Proiti
Giulia Malaguarnera
Nicoletta Bertino
Mariano Malaguarnera
Michele Malaguarnera
Maria Domenica Amaradio
Gabriele Pricoco
Isidoro Di Carlo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBenign liver tumors are common. They do not spread to other areas of the body, and they usually do not pose a serious health risk. In fact, in most cases, benign liver tumors are not diagnosed because patients are asymptomatic. When they are detected, it's usually because the person has had medical imaging tests, such as an ultrasound (US), computed tomography (CT) scan, or magnetic resonance imaging (MRI), for another condition. MATERIALS AND

methodsA search of the literature was made using cancer literature and the PubMed, Scopus, and Web of Science (WOS) database for the following keywords: "hepatic benign tumors", "hepatic cystic tumors", "polycystic liver disease", "liver macroregenerative nodules", "hepatic mesenchymal hamartoma", "hepatic angiomyolipoma", "biliary cystadenoma", and "nodular regenerative hyperplasia". DISCUSSION AND

conclusionHepatocellular carcinoma (HCC) is one of the most common malignant tumors in some areas of the world; there is an increasing incidence worldwide. Approximately 750,000 new cases are reported per year. More than 75 % of cases occur in the Asia-Pacific region, largely in association with chronic hepatitis B virus (HBV) infection. The incidence of HCC is increasing in the USA and Europe because of the increased incidence of hepatitis C virus (HCV) infection. Unlike the liver HCC, benign tumors are less frequent. However, they represent a chapter always more interesting of liver disease. In fact, a careful differential diagnosis with the forms of malignant tumor is often required in such a way so as to direct the patient to the correct therapy. In conclusion, many of these tumors present with typical features in various imaging studies. On occasions, biopsies are required, and/or surgical removal is needed. In the majority of cases of benign hepatic tumors, no treatment is indicated. The main indication for treatment is the presence of significant clinical symptoms or suspicion of malignancy or fear of malignant transformation.

Indexed as

CystsHumansLiver DiseasesLiver NeoplasmsMultimodal ImagingPrognosis

Identifiers

PMID24510731
PMCPMC7101630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.